Transverse myelitis in primary Sjögren's syndrome: usefulness of low-dose oral cyclophosphamide rather than pulse therapy.
Quartuccio
L
L
Ferraccioli
G F
GF
De Vita
S
S
D000284:Administration, Oral; D000368:Aged; D018501:Antirheumatic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D009188:Myelitis, Transverse / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D020551:Pulse Therapy, Drug; D012859:Sjogren's Syndrome / Q000150:complications* / Q000473:pathology
D018501:Antirheumatic Agents; D003520:Cyclophosphamide